IMMUNITYBIO, INC. Expense Breakdown
No Expense Breakdown for IBRX on this site yet.
- 2026-06-30: Reportable $298.00K.
- 2025-06-30: Reportable $136.00K.
Source checked: the stored Expense Breakdown page for IBRX.
Expenses by product
Cost of sales: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $298.00K |
|---|
| 2025-06-30 | $136.00K |
|---|
Income Tax Expense (Benefit): each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $0.00 |
|---|
| 2025-06-30 | $269.00K |
|---|
Operating expenses: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $112.64M |
|---|
| 2025-06-30 | $97.57M |
|---|
Research and development: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $60.82M |
|---|
| 2025-06-30 | $55.24M |
|---|
Research And Development Expense External: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $10.42M |
|---|
| 2025-06-30 | $8.55M |
|---|
Research And Development Expense Internal: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $50.39M |
|---|
| 2025-06-30 | $46.68M |
|---|
Research And Development Expense Internal Equipment Depreciation And Facility Costs: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $13.41M |
|---|
| 2025-06-30 | $13.11M |
|---|
Research And Development Expense Internal Other Costs: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $10.38M |
|---|
| 2025-06-30 | $9.94M |
|---|
Research And Development Expense Internal Personnel Related Costs: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $26.60M |
|---|
| 2025-06-30 | $23.63M |
|---|
Selling, General and Administrative Expense: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $51.82M |
|---|
| 2025-06-30 | $42.34M |
|---|